Can innate immunity be enhanced to treat microbial infections?

[1]  M. Fares,et al.  Evidence of Positively Selected Sites in Mammalian α-Defensins , 2004 .

[2]  R. Hancock,et al.  The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes1 , 2004, The Journal of Immunology.

[3]  R. Flavell,et al.  Shielding the double‐edged sword: negative regulation of the innate immune system , 2004, Journal of leukocyte biology.

[4]  B. Finlay,et al.  Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Philpott,et al.  Innate immunity via Toll-like receptors and Nod proteins. , 2004, Current opinion in microbiology.

[6]  B. Beutler.  Innate immunity: an overview. , 2004, Molecular immunology.

[7]  T. Falla,et al.  Cationic antimicrobial peptides – an update , 2004, Expert opinion on investigational drugs.

[8]  Robert E. W. Hancock,et al.  The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization1 , 2004, The Journal of Immunology.

[9]  T. Sawyer.  Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors , 2004, Expert opinion on investigational drugs.

[10]  K. Rabe,et al.  The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor 1 , 2003, The Journal of Immunology.

[11]  S. Akira,et al.  Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. , 2003, Immunity.

[12]  J. Holmgren,et al.  Orally Administered CpG Oligodeoxynucleotide Induces Production of CXC and CC Chemokines in the Gastric Mucosa and Suppresses Bacterial Colonization in a Mouse Model of Helicobacter pylori Infection , 2003, Infection and Immunity.

[13]  U. Hengge,et al.  Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum , 2003, The British journal of dermatology.

[14]  Zhenghong Yuan,et al.  Toll‐like receptor‐9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin , 2003, Immunology.

[15]  S. Akira,et al.  Mycobacterial Infection in MyD88‐Deficient Mice , 2003, Microbiology and immunology.

[16]  J. Dorin,et al.  Rapid sequence divergence in mammalian β-defensins by adaptive evolution , 2003 .

[17]  L. Kwak,et al.  Roles of antimicrobial peptides such as defensins in innate and adaptive immunity , 2003, Annals of the rheumatic diseases.

[18]  S. Akira,et al.  MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis , 2003, The Journal of experimental medicine.

[19]  C. Hackett.  Innate immune activation as a broad-spectrum biodefense strategy , 2003, Journal of Allergy and Clinical Immunology.

[20]  D. Klinman,et al.  Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. , 2003, Clinical immunology.

[21]  U. Dittmer,et al.  Treatment of infectious diseases with immunostimulatory oligodeoxynucleotides containing CpG motifs. , 2003, Current opinion in microbiology.

[22]  D. Hoover,et al.  Many chemokines including CCL20/MIP‐3α display antimicrobial activity , 2003 .

[23]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature reviews. Immunology.

[24]  D. Kuhns,et al.  Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections , 2003, The Journal of experimental medicine.

[25]  H. Lee,et al.  CpG motif in synthetic ODN primes respiratory burst of olive flounder Paralichthys olivaceus phagocytes and enhances protection against Edwardsiella tarda. , 2003, Diseases of aquatic organisms.

[26]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[27]  K. Herzig,et al.  Antimicrobial peptides in innate immunity of the human intestine , 2003, Journal of Gastroenterology.

[28]  Piero Carninci,et al.  Genetic control of the innate immune response , 2003, BMC Immunology.

[29]  Carrie M. Rosenberger,et al.  Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens , 2003, Nature Reviews Molecular Cell Biology.

[30]  N. Salzman,et al.  Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin , 2003, Nature.

[31]  Richard D Emes,et al.  Comparison of the genomes of human and mouse lays the foundation of genome zoology. , 2003, Human molecular genetics.

[32]  L. Babiuk,et al.  Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs , 2003, Infection and Immunity.

[33]  Takaaki Ohtake,et al.  Biology and clinical relevance of naturally occurring antimicrobial peptides. , 2002, The Journal of allergy and clinical immunology.

[34]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[35]  M. Hornef,et al.  Bacterial strategies for overcoming host innate and adaptive immune responses , 2002, Nature Immunology.

[36]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[37]  R. Coler,et al.  Taking toll: lipid A mimetics as adjuvants and immunomodulators. , 2002, Trends in microbiology.

[38]  James M. Wilson,et al.  β-Defensin 1 Contributes to Pulmonary Innate Immunity in Mice , 2002, Infection and Immunity.

[39]  K. Iwabuchi,et al.  A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis , 2002, Immunology.

[40]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[41]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[42]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[43]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[44]  Chi-Chao Chan,et al.  Therapeutic Applications of Antiflammin Peptides in Experimental Ocular Inflammation , 2000, Annals of the New York Academy of Sciences.

[45]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[46]  B. Finlay,et al.  An α-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression1 , 2000, The Journal of Immunology.

[47]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[48]  G. H. Gudmundsson,et al.  Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.

[49]  S. Stibitz,et al.  Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. , 1999, Journal of immunology.

[50]  K. Heeg,et al.  CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. , 1998, Journal of immunology.

[51]  R. Hancock,et al.  Antiendotoxin activity of cationic peptide antimicrobial agents , 1996, Infection and immunity.

[52]  D. Dunn,et al.  Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. , 1995, Surgery.

[53]  B. Gray,et al.  Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils , 1994, Infection and immunity.

[54]  S. Holland,et al.  Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. , 1994, The New England journal of medicine.

[55]  P. Ghezzi,et al.  Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. , 1993, Science.

[56]  M. Bevan,et al.  The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens , 2004, Nature Immunology.

[57]  S. Tauszig-Delamasure,et al.  Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections , 2002, Nature Immunology.

[58]  P. Hiemstra,et al.  Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone , 2002, Inflammation Research.

[59]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[60]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[61]  J. Larrick,et al.  Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities. , 1994, Progress in clinical and biological research.